<DOC>
	<DOCNO>NCT01337245</DOCNO>
	<brief_summary>The purpose study see whether new F ( ab ' ) 2 antivenom prevent injury death bite coral snake . Funding Source - FDA OOPD .</brief_summary>
	<brief_title>Emergency Treatment Coral Snake Envenomation With Antivenom</brief_title>
	<detailed_description>Coral snake bite may trivial effect , may cause profound life-threatening respiratory paralysis , depend severity envenomation . Venom toxins target neuromuscular junction , effect typically become apparent hour follow bite , time clinical syndrome may irreversible . Unless neurotoxicity prevent , ventilatory paralysis may cause death require intensive care week bite . Prevention paralysis , historically , involve treat bite victim antivenom . This protocol enable therapeutic use new F ( ab ' ) 2 antivenom management coral snake envenomation . Following coral snake bite , patient meet inclusion/exclusion criterion provide inform consent receive 5 vial antivenom intravenously less 30 minute . Blood assay venom level clinical assessment neurologic status treatment conduct patient follow 22 day safety survival endpoint . The primary endpoint Phase 3 trial survival , comparison historical mortality rate 15 % .</detailed_description>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Snake Bites</mesh_term>
	<mesh_term>Antivenins</mesh_term>
	<criteria>Male female age . Presenting emergency treatment coral snake bite . Prior use coral snake antivenom envenomation . Allergy horse serum .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Envenomation</keyword>
	<keyword>Coral Snake</keyword>
	<keyword>Antivenom</keyword>
	<keyword>Micrurus fulvius</keyword>
</DOC>